Re-Imagining Med Chem Strategies: the Tyranny of the n+1 Compound
DrugBaron
FEBRUARY 7, 2022
That’s the part of the process that’s analgous to the library evolution phase of Galaxy The classical approach beloved of large pharma companies is really a brute-force method: make as many molecules as you can to assemble the SAR.
Let's personalize your content